A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene-and monophasic desogestrel-containing oral contraceptives
P Lacante - Gynecological Endocrinology, 1996 - Taylor & Francis
This was an open-label, multicenter study to compare the cycle control and effect on well-
being of two gestodene-containing and one desogestrel-containing oral contraceptive …
being of two gestodene-containing and one desogestrel-containing oral contraceptive …
A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene-and monophasic desogestrel-containing oral contraceptives
V Bruni, H Croxatto, J De La Cruz, M Dhont… - Gynecological …, 2000 - Taylor & Francis
This was an open-label multicenter study to compare the cycle control and effect on well-
being of two oral contraceptives containing gestodene and one containing desogestrel. A …
being of two oral contraceptives containing gestodene and one containing desogestrel. A …
Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial
F Weber-Diehl, J Lehnen, U Lachnit - Contraception, 1993 - Elsevier
Two triphasic oral contraceptives containing either gestodene or norethindrone as the
progestogenic compound combined with ethinyl estradiol were compared in a randomized …
progestogenic compound combined with ethinyl estradiol were compared in a randomized …
The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 µg and ethinylestradiol 15 µg
Gestodene Study Group 322 - The European Journal of …, 1999 - Taylor & Francis
Objectives: The safety and contraceptive efficacy of a new 24-day regimen of an oral
contraceptive combination containing gestodene (GTD) 60 µg and ethinylestradiol (EE) 15 …
contraceptive combination containing gestodene (GTD) 60 µg and ethinylestradiol (EE) 15 …
Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 µg/ethinylestradiol 15 µg and a 21-day regimen of desogestrel 150 µg/ethinylestradiol 20 µg
Gestodene Study Group 324 - The European Journal of …, 1999 - Taylor & Francis
Objectives: This multicenter, open-label study was conducted to compare the cycle control,
efficacy and safety of a 24-day regimen of a new ultra-low-dose oral contraceptive …
efficacy and safety of a 24-day regimen of a new ultra-low-dose oral contraceptive …
A clinical overview of a new triphasic contraceptive containing gestodene.
T Christie - International Journal of Fertility, 1989 - europepmc.org
In three ongoing open studies conducted by 50 investigators in Europe, South America, and
New Zealand, 639 subjects followed a new triphasic regimen of gestodene (GTD) and …
New Zealand, 639 subjects followed a new triphasic regimen of gestodene (GTD) and …
A comparison of cycle control, efficacy, and side effects among healthy Thai women between two low-dose oral contraceptives containing 20 μg ethinylestradio1/75 μg …
S Taneepanichskul, R Kriengsinyot, U Jaisamrarn - Contraception, 2002 - Elsevier
The purpose of this study was to compare cycle control, efficacy and side effects of an oral
contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene, with a reference …
contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene, with a reference …
Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene
HW Halbe, NR De Melo, L Bahamondes… - … European Journal of …, 1998 - Taylor & Francis
Objective To assess the contraceptive efficacy, cycle control and acceptability of two
monophasic oral contraceptives containing either 30 µg ethinylestradiol plus 150 µg …
monophasic oral contraceptives containing either 30 µg ethinylestradiol plus 150 µg …
Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 μg and …
IC Barbosa, C Isaia Filho, D Faggion Jr, EC Baracat - Contraception, 2006 - Elsevier
OBJECTIVE: A prospective, open-label, noncomparative, multicenter study was carried out
in 163 women aged 18–39 (mean 25±5 years), who used an ultra-low-dose oral …
in 163 women aged 18–39 (mean 25±5 years), who used an ultra-low-dose oral …
Safety and efficacy of a triphasic oral contraceptive containing desogestrel: results of three multicenter trials
P Darney - Contraception, 1993 - Elsevier
This report combines the data obtained in three multicenter efficacy studies with a new
triphasic oral contraceptive combination containing desogestrel (DSG) and ethinyl estradiol …
triphasic oral contraceptive combination containing desogestrel (DSG) and ethinyl estradiol …